InvestorsHub Logo
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: None

Thursday, 07/02/2020 8:41:56 AM

Thursday, July 02, 2020 8:41:56 AM

Post# of 182977
KTOV Kitov Pharmaceuticals CEO reports over $60M in cash by the end of Jue
KTOV has cash for next four years "In summary, we look forward to further advancing our commercial and clinical activities by leveraging our strong cash position. Our current cash runway is expected to support our currently planned activities into at least 2024, beyond multiple anticipated clinical milestones, and we believe we are well-funded to execute our strategic plans."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.